Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vulcan Two Group PLC ( (GB:VUL) ) has issued an update.
Vulcan Two Group plc, which aims to build the UK’s leading regulated ePharmacy through a buy-and-build strategy, has issued its Admission Document to shareholders, outlining details of recently announced acquisitions and a placing. The document also includes notice of a general meeting scheduled for 17 March 2026 in London, where shareholders will vote on the proposed resolutions.
The board has unanimously backed the acquisitions and the placing as being in the best interests of the company and its investors, and directors intend to vote their 22.3% aggregate stake in favour. The move underlines management’s commitment to the growth strategy, and the publication of the Admission Document and proxy form on the company’s website marks a key step toward securing shareholder approval and advancing Vulcan Two’s expansion plans in the ePharmacy market.
More about Vulcan Two Group PLC
Vulcan Two Group plc is a UK-based company pursuing a buy-and-build strategy to create the country’s leading regulated ePharmacy. It operates in the online pharmacy and digital healthcare sector, focusing on consolidating and scaling ePharmacy assets under a regulated framework to serve the UK market.
Average Trading Volume: 5,262
Technical Sentiment Signal: Strong Sell
For detailed information about VUL stock, go to TipRanks’ Stock Analysis page.